Spero Therapeutics
Kerri Sellers currently serves as the Corporate Communications Manager at Spero Therapeutics, a position held since January 2022, and previously worked as the Senior Executive Assistant to the CEO. Prior to Spero Therapeutics, Kerri was employed at Biogen from August 2019 to January 2022 in various executive assistant roles, including support for Medical and Corporate Development teams. Kerri's experience also includes serving as an Executive Assistant at Enzyvant and Biogen, as well as administrative leadership at Rickes Associates and other companies, where key responsibilities included strategic planning, marketing development, and executive support. Kerri holds a Project Management Certificate from Cornell University and has a diverse background in sales management and photography.
This person is not in any teams
Spero Therapeutics
2 followers
Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a pipeline of novel and highly differentiated antibacterial and rare disease product candidates focused on patients' unmet needs with multi-drug resistant (MDR) bacterial infections.